Senate Caucus will work with House Caucus to raise awareness, advance policies and support research
Site Search
Bill Would Remove Barrier to Clinical Research for Rare Diseases by Ensuring that Clinical Trial Participants Don't Lose Critical Health Benefits
Legislation Would Remove Financial Penalties for Participating in Research Studies
New Bill Would Remove Financial Penalties for Participating in Research Studies
Connecticut and Texas Last to Join Others in Testing for Life-threatening Disease
The Cystic Fibrosis Foundation announced the appointment of Marc Ginsky as executive vice president and chief operating officer. Mr. Ginsky will oversee the Foundation's day-to-day operations with a focus on field management, information technology and the Foundation's infrastructure.
NCQA Honors The Foundation for Leadership in Improving Care
Robert J. Beall, Ph.D., today announced he will step down as president and chief executive officer of the Cystic Fibrosis Foundation, effective December 31, 2015. Preston W. Campbell III, M.D., currently the Foundation's executive vice president for medical affairs, will succeed Dr. Beall as president and CEO.